Evidence map›Paper›PMID 25400545›Full record

ArticleFrontiers in molecular neuroscience2014

A transgenic mouse line for collecting ribosome-bound mRNA using the tetracycline transactivator system.

Laurel Drane, Joshua A Ainsley, Mark R Mayford, Leon G Reijmers

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Expanding Toolkit of Translating Ribosome Affinity Purification.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Laurel DraneDepartment of Neuroscience, School of Medicine, Tufts University Boston, MA, USA ; Graduate Program in Neuroscience, Sackler School of Graduate Biomedical Sciences, Tufts University Boston, MA, USA.
Joshua A AinsleyDepartment of Neuroscience, School of Medicine, Tufts University Boston, MA, USA.
Mark R MayfordDepartment of Molecular and Cellular Neuroscience, The Scripps Research Institute La Jolla, CA, USA.
Leon G ReijmersDepartment of Neuroscience, School of Medicine, Tufts University Boston, MA, USA.
Tufts University · USScripps Research Institute · US

Funding

TUSM/T-NEMC CENTER FOR NEUROSCIENCE RESEARCH - Imaging CoreP30NS047243 · NINDS · TUFTS UNIVERSITY BOSTON · PI JACKSON, F ROB · 2003 to 2017
$10.0M
REGULATED GENETIC STUDIES OF MEMORY FORMATIONR01MH057368 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MAYFORD, MARK R · 1997 to 2017
$5.9M
Molecular Analysis of Functional Neural CircuitsDP2OD006446 · OD · TUFTS UNIVERSITY BOSTON · PI REIJMERS, LEON · 2009 to 2009
$2.5M
Synapse Neurobiology Training ProgramT32NS061764 · NINDS · TUFTS UNIVERSITY BOSTON · PI BIEDERER, THOMAS · 2009 to 2019
$1.7M
Tools for genome-wide profiling of mRNA translated in in-vivo dendritesR21MH099794 · NIMH · TUFTS UNIVERSITY BOSTON · PI REIJMERS, LEON · 2012 to 2013
$446k
NIH HHS DP2 OD006446NIMH NIH HHS R01 MH057368NIMH NIH HHS R21 MH099794NINDS NIH HHS P30 NS047243NINDS NIH HHS T32 NS061764
6 · The paper itself

Abstract

Acquiring the gene expression profiles of specific neuronal cell-types is important for understanding their molecular identities. Genome-wide gene expression profiles of genetically defined cell-types can be acquired by collecting and sequencing mRNA that is bound to epitope-tagged ribosomes (TRAP; translating ribosome affinity purification). Here, we introduce a transgenic mouse model that combines the TRAP technique with the tetracycline transactivator (tTA) system by expressing EGFP-tagged ribosomal protein L10a (EGFP-L10a) under control of the tetracycline response element (tetO-TRAP). This allows both spatial control of EGFP-L10a expression through cell-type specific tTA expression, as well as temporal regulation by inhibiting transgene expression through the administration of doxycycline. We show that crossing tetO-TRAP mice with transgenic mice expressing tTA under the Camk2a promoter (Camk2a-tTA) results in offspring with cell-type specific expression of EGFP-L10a in CA1 pyramidal neurons and medium spiny neurons in the striatum. Co-immunoprecipitation confirmed that EGFP-L10a integrates into a functional ribosomal complex. In addition, collection of ribosome-bound mRNA from the hippocampus yielded the expected enrichment of genes expressed in CA1 pyramidal neurons, as well as a depletion of genes expressed in other hippocampal cell-types. Finally, we show that crossing tetO-TRAP mice with transgenic Fos-tTA mice enables the expression of EGFP-L10a in CA1 pyramidal neurons that are activated during a fear conditioning trial. The tetO-TRAP mouse can be combined with other tTA mouse lines to enable gene expression profiling of a variety of different cell-types.

Indexed as

CA1 pyramidal neuronCamk2aFostetracycline transactivatorTRAP

Identifiers

PMID25400545
PMCPMC4212621
OpenAlexW1976549907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.